Multimodal Targeted Deep Sequencing of Circulating Tumor Cells and Matched Cell-Free DNA Provides a More Comprehensive Tool to Identify Therapeutic Targets in Metastatic Breast Cancer Patients.

Keup, Corinna; Storbeck, Markus; Hauch, Siegfried; Hahn, Peter; Sprenger-Haussels, Markus; Hoffmann, Oliver; Kimmig, Rainer; Kasimir-Bauer, Sabine

Keup, Corinna; Storbeck, Markus; Hauch, Siegfried; Hahn, Peter; Sprenger-Haussels, Markus; Hoffmann, Oliver; Kimmig, Rainer; Kasimir-Bauer, Sabine.

Afiliação

Keup C; Department of Gynecology and Obstetrics, University Hospital of Essen, 45122 Essen, Germany.
Storbeck M; QIAGEN, 40724 Hilden, Germany.
Hauch S; QIAGEN, 40724 Hilden, Germany.
Hahn P; QIAGEN, 40724 Hilden, Germany.
Sprenger-Haussels M; QIAGEN, 40724 Hilden, Germany.
Hoffmann O; Department of Gynecology and Obstetrics, University Hospital of Essen, 45122 Essen, Germany.
Kimmig R; Department of Gynecology and Obstetrics, University Hospital of Essen, 45122 Essen, Germany.
Kasimir-Bauer S; Department of Gynecology and Obstetrics, University Hospital of Essen, 45122 Essen, Germany.

Cancers (Basel) ; 12(5)2020 Apr 27.

Article em En | MEDLINE | ID: mdl-32349306

Palavras-chave

cell-free DNA; circulating tumor DNA; circulating tumor cells; liquid biopsy; metastatic breast cancer patients; multi-parametric; multimodal; next-generation sequencing; therapy stratification; unique molecular indices

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google